FLINT, Mich. – Oct. 10, 2016 – The nation’s largest independent specialty pharmacy observes American Pharmacists Month by celebrating pharmacists in specialty with multimedia campaign.

Diplomat Pharmacy, Inc. (NYSE: DPLO) is celebrating American Pharmacists Month with a campaign to honor pharmacists in specialty and explore the myths, facts, and possibilities of what a pharmacist in specialty can do for you.

Diplomat released a series of videos in which children are asked about the world of pharmacy. Watch the videos at diplomat.is/american-pharmacists-month/.

October is American Pharmacists Month, started by the American Society of Health-System Pharmacists. Throughout its history, Pharmacists Month has served to educate the public on pharmacy-related topics.

“At Diplomat, pharmacist play a significant role in the delivery of care to patients,” Diplomat CEO and Chairman Phil Hagerman said. “They monitor and prevent drug interactions, consult prescribers on new and emerging treatment options, and help patients understand how to use their medications safely and effectively. This campaign gives us the opportunity to recognize pharmacists in specialty.”


Forward-Looking Statements

This press release contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements give current expectations or forecasts of future events or our future financial or operating performance. The forward-looking statements contained in this press release are based on management’s good-faith belief and reasonable judgment based on current information. These statements are qualified by important risks and uncertainties, many of which are beyond our control, that could cause our actual results to differ materially from those forecasted or indicated by such forward-looking statements. For a discussion of such risks and uncertainties, you should review Diplomat’s filings with the Securities and Exchange Commission, including “Risk Factors” in Diplomat’s Annual Report on Form 10-K for the year ended December 31, 2015 and in subsequent reports filed with or furnished to the Securities and Exchange Commission. Except as may be required by any applicable laws, Diplomat assumes no obligation to publicly update such forward-looking statements, which are made as of the date hereof or the earlier date specified herein, whether as a result of new information, future developments or otherwise. 

About Diplomat

Diplomat (NYSE: DPLO) serves patients and physicians in all 50 states. Headquartered in Flint, Michigan, the company focuses on medication management programs for people with complex chronic diseases, including oncology, immunology, hepatitis, multiple sclerosis, specialized infusion therapy and many other serious or long-term conditions. Diplomat opened its doors in 1975 as a neighborhood pharmacy with one essential tenet: “Take good care of patients and the rest falls into place.” Today, that tradition continues—always focused on improving patient care and clinical adherence. For more information visit diplomat.is.


Kali Lucas, Public Relations Specialist
810.768.9580 | press@diplomat.is